Fig. 2From: Clinical and economic burden of pneumococcal disease in US adults aged 19–64 years with chronic or immunocompromising diseases: an observational database studyMean cost per episode of ACP and IPD in healthy and high-risk adults 19–64 years. *P < 0.0001. ACP all-cause pneumonia, IPD invasive pneumococcal diseaseBack to article page